169 related articles for article (PubMed ID: 6157242)
1. Tumor markers in urologic cancer.
Javadpour N
Urology; 1980 Aug; 16(2):127-36. PubMed ID: 6157242
[No Abstract] [Full Text] [Related]
2. Tumour markers in urology: aids in cancer diagnosis and management.
Wahren B
Urol Res; 1979 Jun; 7(2):57-67. PubMed ID: 89748
[No Abstract] [Full Text] [Related]
3. Immunocytochemical localization of various markers in cancer cells and tumors. Diagnostic and therapeutic strategy in urologic cancers.
Javadpour N
Urology; 1983 Jan; 21(1):1-7. PubMed ID: 6186063
[No Abstract] [Full Text] [Related]
4. Serum and cellular biologic tumor markers in patients with urologic cancer.
Javadpour N
Hum Pathol; 1979 Sep; 10(5):557-68. PubMed ID: 93569
[TBL] [Abstract][Full Text] [Related]
5. [Significance of current bio- and molecular-markers in urological cancers].
Shimazui T; Akaza H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1008-14. PubMed ID: 15272577
[TBL] [Abstract][Full Text] [Related]
6. Symposium on Uropathology.
Hum Pathol; 1979 Sep; 10(5):497-584. PubMed ID: 93566
[No Abstract] [Full Text] [Related]
7. Tumor markers in testicular cancer--an update.
Javadpour N
Prog Clin Biol Res; 1985; 203():141-54. PubMed ID: 2421328
[No Abstract] [Full Text] [Related]
8. Tumor markers in urology.
Grossman HB
Semin Urol; 1985 Feb; 3(1):10-7. PubMed ID: 2408306
[No Abstract] [Full Text] [Related]
9. [Use of radioimmunoanalysis for tumor markers in the diagnosis of carcinoma of the testes and prostate].
Kausitz J
Bratisl Lek Listy; 1988 Oct; 89(10):715-24. PubMed ID: 2463063
[No Abstract] [Full Text] [Related]
10. Germ cell tumor of the testis.
Javadpour N
CA Cancer J Clin; 1980; 30(5):242-55. PubMed ID: 6157458
[No Abstract] [Full Text] [Related]
11. [Pregnancy-specific beta 1-glycoprotein: a tumor marker].
Horne CH; Bremner RD
Ric Clin Lab; 1984; 14 Suppl 2():33-8. PubMed ID: 6085182
[No Abstract] [Full Text] [Related]
12. [The current concept of tumor markers in oncologic urology--cytoplasmic markers].
Ianev V; Kumanov Kh; Tsvetkov D; Ianev Ia
Khirurgiia (Sofiia); 1989; 42(5):15-8. PubMed ID: 2483188
[TBL] [Abstract][Full Text] [Related]
13. [Immunologic aspects in urologic tumors].
Ackermann R
Med Klin; 1980 Jun; 75(12):436-41. PubMed ID: 6156392
[No Abstract] [Full Text] [Related]
14. Management of seminoma based on tumor markers.
Javadpour N
Urol Clin North Am; 1980 Oct; 7(3):773-81. PubMed ID: 6161465
[No Abstract] [Full Text] [Related]
15. [Metastasis and markers].
Trinchieri A; Rovera F; Longo G; Del Nero A; Zanetti G; Austoni E
Arch Ital Urol Nefrol Androl; 1992 Mar; 64(1):27-30. PubMed ID: 1373913
[TBL] [Abstract][Full Text] [Related]
16. Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"?
Netto GJ
Adv Anat Pathol; 2013 May; 20(3):175-203. PubMed ID: 23574774
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical discordance in localization of pregnancy specific beta-1 glycoprotein, alpha-fetoprotein and human chorionic gonadotropin in testicular cancers.
Javadpour N; Utz M; Soares T
J Urol; 1980 Nov; 124(5):615-6. PubMed ID: 6161257
[TBL] [Abstract][Full Text] [Related]
18. [Tumor markers in urological malignancies].
Kuriyama M
Nihon Rinsho; 1996 Jun; 54(6):1631-6. PubMed ID: 8691621
[TBL] [Abstract][Full Text] [Related]
19. [Uronephrological and urogenital tumors: the urologist's viewpoint].
Leisinger HJ
Rev Med Suisse Romande; 1995 Mar; 115(3):227-8. PubMed ID: 7777761
[No Abstract] [Full Text] [Related]
20. Diagnostic value of markers AFP, HCG and LDH in advanced germ cell tumors before and after cytostasis resp.
Jaeger N; Vahlensieck W
Prog Clin Biol Res; 1985; 203():107-16. PubMed ID: 2421323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
